CA3071096A1 - Co-administration de minocycline et de colistine pour reduire le risque de lesion renale aigue - Google Patents

Co-administration de minocycline et de colistine pour reduire le risque de lesion renale aigue Download PDF

Info

Publication number
CA3071096A1
CA3071096A1 CA3071096A CA3071096A CA3071096A1 CA 3071096 A1 CA3071096 A1 CA 3071096A1 CA 3071096 A CA3071096 A CA 3071096A CA 3071096 A CA3071096 A CA 3071096A CA 3071096 A1 CA3071096 A1 CA 3071096A1
Authority
CA
Canada
Prior art keywords
subject
administration
colistin
minocycline
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3071096A
Other languages
English (en)
Inventor
Michael N. Dudley
David C. Griffith
Original Assignee
Rempex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rempex Pharmaceuticals Inc filed Critical Rempex Pharmaceuticals Inc
Publication of CA3071096A1 publication Critical patent/CA3071096A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des méthodes de traitement d'une infection bactérienne par l'utilisation d'une combinaison de minocycline et de colistine pour réduire le risque de lésion rénale aiguë.
CA3071096A 2017-01-09 2018-01-08 Co-administration de minocycline et de colistine pour reduire le risque de lesion renale aigue Pending CA3071096A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762444235P 2017-01-09 2017-01-09
US62/444,235 2017-01-09
US201762488528P 2017-04-21 2017-04-21
US62/488,528 2017-04-21
PCT/US2018/012809 WO2018129463A1 (fr) 2017-01-09 2018-01-08 Co-administration de minocycline et de colistine pour réduire le risque de lésion rénale aiguë

Publications (1)

Publication Number Publication Date
CA3071096A1 true CA3071096A1 (fr) 2018-07-12

Family

ID=62790915

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3071096A Pending CA3071096A1 (fr) 2017-01-09 2018-01-08 Co-administration de minocycline et de colistine pour reduire le risque de lesion renale aigue

Country Status (3)

Country Link
EP (1) EP3582786A4 (fr)
CA (1) CA3071096A1 (fr)
WO (1) WO2018129463A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3810114A4 (fr) * 2018-04-30 2022-01-19 Melinta Therapeutics, Inc. Procédés de traitement d'infections bactériennes à l'aide d'oritavancine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016013986A1 (fr) * 2014-07-25 2016-01-28 Agency For Science, Technology And Research Compositions antibiotiques pour traiter des infections bactériennes

Also Published As

Publication number Publication date
WO2018129463A1 (fr) 2018-07-12
EP3582786A1 (fr) 2019-12-25
EP3582786A4 (fr) 2020-12-23

Similar Documents

Publication Publication Date Title
US20250325522A1 (en) Biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders
AU2010258888B2 (en) Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
US20260102374A1 (en) Methods of treating bacterial infections
WO2020198039A1 (fr) Kétamine pour le traitement de déficits du traitement sensoriel
AU2019354784B2 (en) Biphenyl sulfonamide compounds for the treatment of type IV collagen diseases
US20260097005A1 (en) Ketamine and ketamine/nap for treatment of adnp syndrome and related neurological conditions
CA3071096A1 (fr) Co-administration de minocycline et de colistine pour reduire le risque de lesion renale aigue
US20210052608A1 (en) Methods of treating bacterial infections with minocycline
WO2024073672A1 (fr) Polythérapie avec du sparsentan et un inhibiteur de sglt2 pour le traitement de maladies ou de troubles rénaux
WO2025064688A1 (fr) Sparsentan pour le traitement de la néphropathie à immunoglobulines a (igan)
HK40059411B (en) Biphenyl sulfonamide compounds for the treatment of type iv collagen diseases
HK40059411A (en) Biphenyl sulfonamide compounds for the treatment of type iv collagen diseases

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220928

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-2-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20251110

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260106

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260219